Cara Therapeutics

3 followers

‌

Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Christopher Posner

CEO, President & Director

Christopher Posner

Collapse

Ryan Maynard

Chief Financial Officer

Frédérique Menzaghi

Chief Scientific Officer, SVP Research & Development

Jo Goncalves

Chief Medical Officer

Scott Terrillion

General Counsel, Secretary & Chief Compliance Officer

Eric Vandal

SVP, Commercial

Beth Weinberg

SVP, Regulatory Affairs & QA

Stephen O’Connor

Vice President CMC Technical Operations

Teams

Research and Development

10 members

Clinical Operations

8 members

Leadership Team

7 members

Regulatory and Quality Assurance Team

2 members

Finance and Accounting

3 members

Similar companies

REVOLUTION Medicines

4 followers

Precigen

3 followers

Immunovant

3 followers

ADMA Biologics

1 follower

Thermo Fisher Scientific

140 followers

Genentech

142 followers

Gilead Sciences

118 followers

Biogen

107 followers

Regeneron

87 followers

Illumina

65 followers

Verily Life Sciences

36 followers

Discover companies